Surmodics gets US FDA approval for SurVeil drug-coated balloon
The device is intended for use in percutaneous transluminal angioplasty, following appropriate vessel preparation, for treating de novo…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jun 23
The device is intended for use in percutaneous transluminal angioplasty, following appropriate vessel preparation, for treating de novo…
20 Jun 23
SKYCovione is a self-assembled nanoparticle vaccine targeting the receptor binding domain of the SARS-CoV-2 Spike protein for SARS-CoV-2
20 Jun 23
New Supplement Developed to Support Restful Sleep and a Healthy Gut Microbiome
19 Jun 23
Columvi (glofitamab-gxbm) is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and…
19 Jun 23
Spread over 60,000ft2, the custom-built Vaxxas Biomedical Facility will act as the firm’s global headquarters to scale up…
19 Jun 23
The study will use the proprietary combination of SciSparc's Palmitoylethanolamide and Clearmind's Methoxy-2-aminoindane, a proprietary psychedelic treatment for…
19 Jun 23
With the acquisition, Coherus will get access to Surface Oncology’s two differentiated clinical-stage assets, SRF388, a novel IL-27-targeted…
19 Jun 23
With this development, Prometheus now operates as a fully-owned subsidiary of Merck, and the common stock of Prometheus…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Jun 23
TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling potent anti-tumor responses
19 Jun 23
BAT2206 is a proposed biosimilar to Janssen’s Stelara1, which is currently approved in Brazil for the treatment of…